Numinus Offering Ketamine Assisted Psychotherapy At Two Clinics in Canada, Psychedelic Neurology Centre On The Horizon Oct 8, 2021
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MYND Diagnostics Ltd. Oct 7, 2021
Delic Labs Applies for Dealer’s License to Commercialize Psychedelics Research, Health Exemption to Test MDMA and… Oct 6, 2021
Awakn Life Sciences Announces Closing of Acquisition of Leading Ketamine-Assisted Psychotherapy Clinic in Norway Oct 5, 2021
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr.… Oct 5, 2021
Changing The Public’s View On Psychedelic Therapeutics With Mydecine Innovation’s Dr. Jetly Oct 1, 2021
